Designing a model to estimate the burden of COVID-19 in Iran.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 21 11 2023
accepted: 28 08 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

The novel coronavirus disease 2019 (COVID-19) is the latest evidence of an epidemic disease resulting in an extraordinary number of infections and claimed several lives, along with extensive economic and social consequences. In response to the emergency situation, countries introduced different policies to address the situation, with different levels of efficacy. This paper outlines the protocol for developing a model to analyze the burden of COVID-19 in Iran and the effect of policies on the incidence and cumulative death of the disease. The importance of the model lies in the fact that no study, according to the authors' best knowledge, tried to quantify the impact of the disease on Iran society and the impact of various implemented interventions on disease control. Based on a systematic review of COVID-19 prediction models and expert interviews, we developed a system dynamics model that not only includes an epidemic part but also considers the impact of various policies implemented by the Ministry of Health. The epidemic model estimates the incidence and mortality of COVID-19 in Iran. The model also intends to evaluate the effect of implemented policies on these outcomes. The model reflects the continuum of COVID-19 infection and care in Iran (of which some of its elements are unique) and key activities and decisions in delivering care. The model is calibrated and validated using data published by the Ministry of Health of Iran. Finally, the study aims to provide evidence of the impact of interventions intended to curb COVID-19 in Iran. Insights provided by the model will be necessary for controlling either future waves of the disease or similar future pandemics.

Identifiants

pubmed: 39333991
doi: 10.1186/s12889-024-19920-w
pii: 10.1186/s12889-024-19920-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2609

Informations de copyright

© 2024. The Author(s).

Références

Milne GJ, Xie S, Poklepovich D, O’Halloran D, Yap M, Whyatt D. A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia. Sci Rep. 2021;11(1):1–10.
doi: 10.1038/s41598-021-91418-6
Rehman AU, Mian SH, Usmani YS, Abidi MH, Mohammed MK, editors. Modeling consequences of COVID-19 and assessing its epidemiological parameters: a System Dynamics Approach. Healthcare: Multidisciplinary Digital Publishing Institute; 2023.
Daoust J-F. Elderly people and responses to COVID-19 in 27 countries. PLoS ONE. 2020;15(7):e0235590.
doi: 10.1371/journal.pone.0235590 pubmed: 32614889 pmcid: 7332014
Shreffler J, Petrey J, Huecker M. The impact of COVID-19 on healthcare worker wellness: a scoping review. Western J Emerg Med. 2020;21(5):1059.
doi: 10.5811/westjem.2020.7.48684
Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, et al. Impact of the COVID-19 pandemic on emergency department visits—United States, January 1, 2019–May 30, 2020. Morb Mortal Wkly Rep. 2020;69(23):699.
doi: 10.15585/mmwr.mm6923e1
Mandal M, Jana S, Nandi SK, Khatua A, Adak S, Kar T, Chaos. Solitons Fractals. 2020;136:109889.
doi: 10.1016/j.chaos.2020.109889
Hu H, Kennedy CM, Kevrekidis PG, Zhang H-K. A modified PINN Approach for Identifiable Compartmental models in Epidemiology with Application to COVID-19. Viruses. 2022;14(11):2464.
doi: 10.3390/v14112464 pubmed: 36366562 pmcid: 9692762
Alshammari FS, Akyildiz FT, Khan MA, Din A, Sunthrayuth P. A stochastic Mathematical Model for understanding the COVID-19 infection using Real Data. Symmetry. 2022;14(12):2521.
doi: 10.3390/sym14122521
Ahmed I, Modu GU, Yusuf A, Kumam P, Yusuf I. A mathematical model of Coronavirus Disease (COVID-19) containing asymptomatic and symptomatic classes. Results Phys. 2021;21:103776.
doi: 10.1016/j.rinp.2020.103776 pubmed: 33432294 pmcid: 7787076
Cui Y, Ni S, Shen S. A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic. BMC Infect Dis. 2021;21:1–12.
doi: 10.1186/s12879-020-05750-9
Li Y, Liu C, Zhao S, Wang Z, Zhao H, Chu S, et al. editors. Simulation Prediction and Control Strategy of COVID-19 Dynamic Contact Network in USA and Various States–Based on Effective Regeneration Number and Improved Discrete SEIQDHR Model. Journal of Physics: Conference Series; 2021: IOP Publishing.
Currie CS, Fowler JW, Kotiadis K, Monks T, Onggo BS, Robertson DA, et al. How simulation modelling can help reduce the impact of COVID-19. J Simul. 2020;14(2):83–97.
doi: 10.1080/17477778.2020.1751570
Silva PC, Batista PV, Lima HS, Alves MA, Guimarães FG, Silva RC. COVID-ABS: an agent-based model of COVID-19 epidemic to simulate health and economic effects of social distancing interventions. Chaos Solitons Fractals. 2020;139:110088.
doi: 10.1016/j.chaos.2020.110088 pubmed: 32834624 pmcid: 7340090
Aldekhyl SS, Arabi YM. Simulation role in preparing for COVID-19. Annals Thorac Med. 2020;15(3):134.
doi: 10.4103/atm.ATM_114_20
Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E et al. Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal. BMJ. 2020;369.
Chang SL, Harding N, Zachreson C, Cliff OM, Prokopenko M. Modelling transmission and control of the COVID-19 pandemic in Australia. Nat Commun. 2020;11(1):5710.
doi: 10.1038/s41467-020-19393-6 pubmed: 33177507 pmcid: 7659014
Scott N, Palmer A, Delport D, Abeysuriya R, Stuart R, Kerr CC, et al. Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting. Med J Aust. 2020;214(2):79–83.
doi: 10.5694/mja2.50845 pubmed: 33207390 pmcid: 7753668
Stutt RO, Retkute R, Bradley M, Gilligan CA, Colvin J. A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’in managing the COVID-19 pandemic. Proceedings of the Royal Society A. 2020;476(2238):20200376.
Oh I-H, Ock M, Jang SY, Go D-S, Kim Y-E, Jung Y-S et al. Years of life lost attributable to COVID-19 in high-incidence countries. J Korean Med Sci. 2020;35(32).
Zia K, Farooq U. COVID-19 outbreak in Oman: model-driven impact analysis and challenges. medRxiv. 2020:2020.04. 02.20050666.
He S, Peng Y, Sun K. SEIR modeling of the COVID-19 and its dynamics. Nonlinear Dyn. 2020;101:1667–80.
doi: 10.1007/s11071-020-05743-y pubmed: 32836803 pmcid: 7301771
Ghaffarzadegan N, Rahmandad H. Simulation-based estimation of the early spread of COVID‐19 in Iran: actual versus confirmed cases. Syst Dynamics Rev. 2020;36(1):101–29.
doi: 10.1002/sdr.1655
Annas S, Pratama MI, Rifandi M, Sanusi W, Side S. Stability analysis and numerical simulation of SEIR model for pandemic COVID-19 spread in Indonesia. Chaos Solitons Fractals. 2020;139:110072.
doi: 10.1016/j.chaos.2020.110072 pubmed: 32834616 pmcid: 7345386
Kazempour Dizaji M, Varahram M, Roozbahani R, Abedini A, Zare A, Kiani A, et al. Simulation of COVID-19 disease epidemic in Iran based on SIR model. Health Sci Monit. 2022;1(1):1–9.
doi: 10.52547/hsm.1.1.1
Chen Z, Kong G. Hospital admission, facility-based isolation, and social distancing: an SEIR model with constrained medical resources. Prod Oper Manage. 2023;32(5):1397–1414. https://doi.org/10.1111/poms.13702 .
Liu Z, Wang XC, Dai J, Li X, Li R. Impacts of COVID-19 pandemic on travel behavior in large cities of China: investigation on the lockdown and reopening phases. J Transp Eng, Part A: Syst. 2022;148(2):05021011.
Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw open. 2022;5(8):e2228008–e.
doi: 10.1001/jamanetworkopen.2022.28008 pubmed: 35994285 pmcid: 9396366
Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput Biol. 2017;13(9):e1005697.
doi: 10.1371/journal.pcbi.1005697 pubmed: 28898249 pmcid: 5609774

Auteurs

Sadegh Ghazanfari (S)

Department of Health Economics and Management, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Meskarpour-Amiri (M)

Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Sayyed-Morteza Hosseini-Shokouh (SM)

Department of Health Economics, Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Department of Health Services Management, Faculty of Health, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Ehsan Teymourzadeh (E)

Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Parisa Mehdizadeh (P)

Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. p.mahdizade@gmail.com.

Mahmood Salesi (M)

Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Research Center for Prevention of Oral and Dental Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH